ImmuPharma (LSE:IMM) Total Payout Ratio : 0.00 (As of Apr. 28, 2024)

View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

ImmuPharma's current Total Payout Ratio is 0.00.

ImmuPharma Total Payout Ratio Historical Data

The historical data trend for ImmuPharma's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuPharma Total Payout Ratio Chart

ImmuPharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Payout Ratio

Get a 7-Day Free Trial

1.24

0.42

1.43

0.54

0.78

ImmuPharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ImmuPharma's Total Payout Ratio

For the Biotechnology subindustry, ImmuPharma's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmuPharma's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmuPharma's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where ImmuPharma's Total Payout Ratio falls into.

ImmuPharma Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

ImmuPharma's Total Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	2.351	+	0)	/	-3.029
	=	0.78

ImmuPharma's Total Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-1.298
	=	0.00

ImmuPharma Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of ImmuPharma's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuPharma (LSE:IMM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

IMM.GB:UK 25I:Germany

Address

One Bartholomew Close, London, GBR, EC1A 7BL

Website

https://www.immupharma.co.uk

ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus and a life-threatening autoimmune disease.

ImmuPharma (LSE:IMM) Headlines

No Headlines